Developer docs
API playgroundTry for free, no card

Search company profiles

21st Century Oncology

Full company profile

uuid002gmbs

Namestring
21st Century Oncology
Legal namestring
21st Century Oncology
Company typeenum
Private
Founded yearint
1983
Descriptiontext

21st Century Oncology presents two distinct identities in the source data. Per firmographic inputs, it is a US for-profit cancer care provider founded in 1983 in Fort Myers, Florida, previously listed on NASDAQ under ticker RTSX, with 1,001-5,000 employees and a $325 million funding round from CPP Investments in 2014 alongside a recorded acquisition of OnCURE Medical in 2013. Historical leadership includes Daniel E. Dosoretz (CEO & Co-Founder), Daniel H. Galmarini (CTO), and Gary Delanois (SVP of Multispecialty Operations).

The currently observable asset — the 21stcenturyoncology.com domain — operates as an international medical tourism information and referral portal rather than a clinical care provider. The site connects patients with oncology treatment facilities across six countries: Germany (Helios Berlin-Buch, Asklepios Barmbek, Bremen-Mitte), Israel (Suraski/Ichilov), Turkey (Anadolu Medical Center), Spain, Czech Republic, and South Korea. The platform publishes educational content on treatment modalities including surgery, radiation therapy (CyberKnife, IORT, HIFU), chemotherapy (HIPEC, PIPAC), immunotherapy, targeted therapy, CAR-T therapy, hormone therapy, stem cell transplant, and chemoembolization.

The business model is an affiliate/referral lead-generation model: patient inquiries submitted via a contact form are routed to partner hospitals. Distribution is content-marketing and SEO-driven, with supplementary social presence on Facebook, Twitter, Instagram, and YouTube under the #TreatingCancer hashtag. No pricing is publicly disclosed. Importantly, the homepage prominently displays paid text-link advertisements for unrelated products (anabolic steroids, sports betting, surrogacy services, marijuana seeds, mattresses, aesthetic clinics), and the site runs on a WordPress "ShopUp Lite" theme — signals that the domain is also being monetized as a low-quality link-selling content property. No parent company, ownership structure, or relationship between the historic US oncology operator and the current international referral site is disclosed in the source materials.

Short descriptiontext

21st Century Oncology operates an international medical tourism referral portal connecting cancer patients with accredited treatment hospitals in Germany, Israel, Turkey, Spain, Czech Republic, and South Korea, monetized through affiliate lead generation and SEO-driven content marketing.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersFort Myers, United States
HQ citystring
Fort Myers
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
cancer treatment referrals, medical tourism platform, oncology information services, international patient coordination, hospital partner network
NAICS code1 code
  • Ambulatory Health Care Services621
SIC code1 code
  • Services-Health Services8000
Product category
Medical Tourism Information Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Hospital Referral/Lead Generation
TypeAffiliate Referral
Description

The company appears to generate revenue through referrals and lead generation for partner hospitals and treatment facilities. Patients inquiring through the platform are connected with partner hospitals for consultation and treatment.

21stcenturyoncology.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Marketing or Sales, Personnel, Technology or R&D, Operations
GTM typeB2C
B2C
Offering typeDigital Commerce or Conte…
Digital Commerce or Content
Core offering1 text field

21st Century Oncology operates an online medical tourism information portal that connects international cancer patients with accredited oncology treatment providers in Germany, Israel, Turkey, Spain, Czech Republic, and South Korea. The platform publishes educational content about cancer therapies (chemoembolization, HIFU, immunotherapy, targeted therapy, CAR-T, radiation, surgery) and profiles partner hospitals, then routes patient inquiries to those partner facilities for consultation and treatment.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Featured hospitals treat over 400,000 patients annually at leading facilities like Suraski Medical Center
+2 more records
Product overview1 text field

21st Century Oncology operates as a medical tourism information portal connecting international patients with cancer treatment providers across multiple countries. The platform aggregates hospital partnerships in Germany (Helios Berlin-Buch, Asklepios Barmbek, Bremen-Mitte), Israel (Ichilov/Suraski), and Turkey (Anadolu Medical Center). The service offers educational content about various oncology treatments including surgery, radiation therapy, chemotherapy, immunotherapy, targeted therapy, hormone therapy, stem cell transplant, chemoembolization, HIFU therapy, and CAR-T cell therapy. The core platform provides information about cancer types, treatment options, and prevention strategies, functioning as a directory and educational resource rather than a direct medical service provider.

Product and service1 record
1Medical Tourism Oncology Information Portal
CategoryMedical Tourism Information Platform
Description

An online healthcare information platform that connects international cancer patients with oncology treatment providers across Germany, Israel, Turkey, Spain, Czech Republic, and South Korea. The portal provides hospital profiles, treatment information, and an inquiry form that routes patients to partner facilities.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Anadolu Medical Center is a leading multi-specialty cancer center in Turkey affiliated with Johns Hopkins Hospital. The partnership provides patients access to advanced treatments including CyberKnife M6, Varian Edge, and TrueBeam STx radiation systems. Anadolu has OECI accreditation and ESMO certification.

2Bremen-Mitte Hospital
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Bremen-Mitte is a multidisciplinary medical center treating 40,000 patients annually. The cancer center is certified by German Cancer Society (DKG) and European Cancer Society (ECC). Offers advanced treatments including NEOliquid liquid biopsy and HIPEC therapy.

21stcenturyoncology.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Helios Berlin-Buch is one of Germany's largest hospitals with over 200,000 patients annually, designated a cancer center by German Cancer Society (DKG). Offers IORT, HIPEC, PIPAC, and RFA treatments. Ranked by Focus magazine and Newsweek in 2021.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Asklepios Klinik Barmbek is part of Germany's largest hospital network, treating over 80,000 patients annually. Its oncology clinic is DKG-accredited. Features Da Vinci Robot, Gamma-knife, and VATS for advanced treatments. Ranked top 5 by MTQA.

5Suraski Medical Center (Ichilov)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Ichilov is a leading multi-specialty clinic in Israel, seeing over 400,000 patients and performing 34,000 operations annually. Ranked top 3 in Israel by Newsweek 2021. Features Novalis TrueBeam STx, Da Vinci robotic system, and CAR-T therapy.

21stcenturyoncology.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Medigo (now part of Allianz Care) is a medical tourism marketplace that helps international patients find and book treatment at accredited providers. It is directly comparable in intermediary model, content-driven discovery, and multi-country specialty hospital network.

TypeDirect peer
Description

BookingHealth is a medical tourism platform that connects international patients with hospitals and clinics across multiple countries, including Germany and Israel. It mirrors 21st Century Oncology in business model (digital intermediary + lead generation) and target audience (cross-border patients seeking specialty treatment).

TypeDirect peer
Description

Treatment in Germany is a medical tourism facilitator focused on routing international patients to German hospitals for oncology, cardiology, and other specialty care. It is highly comparable in country focus (Germany), partner type (DKG-accredited hospitals), and patient acquisition approach (content + SEO).

TypeDirect peer
Description

Qunomedical is a digital health platform that connects patients with vetted clinics and hospitals worldwide, with a strong oncology and specialty focus. It is comparable as a content-and-concierge medical tourism intermediary for international patients.

TypeDirect peer
Description

Clinic Hunter is a European medical tourism platform focused on connecting international patients with clinics and hospitals for specialty treatments. It is comparable in intermediary role, European hospital network, and content-led patient acquisition.

TypeDirect peer
Description

MyMeditravel is a medical tourism platform offering treatment packages across multiple countries and specialties. It is comparable as a content-driven, lead-generation intermediary linking international patients with overseas specialty hospitals.

TypeDirect peer
Description

Medical Departures is a global medical tourism marketplace with verified provider listings, reviews, and booking support. It is directly comparable in business model (intermediary + verified providers) and cross-border specialty focus.

TypeDirect peer
Description

Healthbase is a US-based medical tourism facilitator connecting international patients with partner hospitals abroad. It shares the same US-domestic operating base, intermediary model, and multi-country specialty hospital network.

TypeDirect peer
Description

TourMedical is a medical tourism agency that arranges treatment and travel packages for patients seeking care abroad, with strong Turkey and Europe coverage. It is directly comparable as a cross-border oncology referral platform.

TypeOthers
Description

Springer Nature publishes peer-reviewed oncology content and clinical decision-support resources that international cancer patients and clinicians use. It is comparable to 21st Century Oncology only in the content and educational layer of its offering, not in patient referrals or commercial transactions.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance7 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

21st Century Oncology

Medical Tourism Information Services21stcenturyoncology.com

21st Century Oncology operates an international medical tourism referral portal connecting cancer patients with accredited treatment hospitals in Germany, Israel, Turkey, Spain, Czech Republic, and South Korea, monetized through affiliate lead generation and SEO-driven content marketing.

What 21st Century Oncology does

21st Century Oncology presents two distinct identities in the source data. Per firmographic inputs, it is a US for-profit cancer care provider founded in 1983 in Fort Myers, Florida, previously listed on NASDAQ under ticker RTSX, with 1,001-5,000 employees and a $325 million funding round from CPP Investments in 2014 alongside a recorded acquisition of OnCURE Medical in 2013. Historical leadership includes Daniel E. Dosoretz (CEO & Co-Founder), Daniel H. Galmarini (CTO), and Gary Delanois (SVP of Multispecialty Operations).

The currently observable asset — the 21stcenturyoncology.com domain — operates as an international medical tourism information and referral portal rather than a clinical care provider. The site connects patients with oncology treatment facilities across six countries: Germany (Helios Berlin-Buch, Asklepios Barmbek, Bremen-Mitte), Israel (Suraski/Ichilov), Turkey (Anadolu Medical Center), Spain, Czech Republic, and South Korea. The platform publishes educational content on treatment modalities including surgery, radiation therapy (CyberKnife, IORT, HIFU), chemotherapy (HIPEC, PIPAC), immunotherapy, targeted therapy, CAR-T therapy, hormone therapy, stem cell transplant, and chemoembolization.

The business model is an affiliate/referral lead-generation model: patient inquiries submitted via a contact form are routed to partner hospitals. Distribution is content-marketing and SEO-driven, with supplementary social presence on Facebook, Twitter, Instagram, and YouTube under the #TreatingCancer hashtag. No pricing is publicly disclosed. Importantly, the homepage prominently displays paid text-link advertisements for unrelated products (anabolic steroids, sports betting, surrogacy services, marijuana seeds, mattresses, aesthetic clinics), and the site runs on a WordPress "ShopUp Lite" theme — signals that the domain is also being monetized as a low-quality link-selling content property. No parent company, ownership structure, or relationship between the historic US oncology operator and the current international referral site is disclosed in the source materials.

21st Century Oncology firmographics

Firmographics
Name
21st Century Oncology
Legal name
21st Century Oncology
Website
https://21stcenturyoncology.com
Company type
Private
Founded year
1983
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
21st Century Oncology operates an international medical tourism referral portal connecting cancer patients with accredited treatment hospitals in Germany, Israel, Turkey, Spain, Czech Republic, and South Korea, monetized through affiliate lead generation and SEO-driven content marketing.
Ownership category
akta.pro rank

Where 21st Century Oncology is headquartered

Location

Headquarters

HQ city
Fort Myers
HQ country
United States
HQ region
North America

Markets served

21st Century Oncology business model

Business model
GTM type
B2C
Offering type
Digital Commerce or Content
Cost components
Marketing or Sales, Personnel, Technology or R&D, Operations

Revenue model

  1. Hospital Referral/Lead Generation: The company appears to generate revenue through referrals and lead generation for partner hospitals and treatment facilities. Patients inquiring through the platform are connected with partner hospitals for consultation and treatment.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

21st Century Oncology product offering

Product offering

Core offering

21st Century Oncology operates an online medical tourism information portal that connects international cancer patients with accredited oncology treatment providers in Germany, Israel, Turkey, Spain, Czech Republic, and South Korea. The platform publishes educational content about cancer therapies (chemoembolization, HIFU, immunotherapy, targeted therapy, CAR-T, radiation, surgery) and profiles partner hospitals, then routes patient inquiries to those partner facilities for consultation and treatment.

Product overview

21st Century Oncology operates as a medical tourism information portal connecting international patients with cancer treatment providers across multiple countries. The platform aggregates hospital partnerships in Germany (Helios Berlin-Buch, Asklepios Barmbek, Bremen-Mitte), Israel (Ichilov/Suraski), and Turkey (Anadolu Medical Center). The service offers educational content about various oncology treatments including surgery, radiation therapy, chemotherapy, immunotherapy, targeted therapy, hormone therapy, stem cell transplant, chemoembolization, HIFU therapy, and CAR-T cell therapy. The core platform provides information about cancer types, treatment options, and prevention strategies, functioning as a directory and educational resource rather than a direct medical service provider.

Differentiator

Problem solved

Functional benefit

Products and services

  • Medical Tourism Oncology Information Portal An online healthcare information platform that connects international cancer patients with oncology treatment providers across Germany, Israel, Turkey, Spain, Czech Republic, and South Korea. The portal provides hospital profiles, treatment information, and an inquiry form that routes patients to partner facilities.

Quantifiable outcome

  • Featured hospitals treat over 400,000 patients annually at leading facilities like Suraski Medical Center
  • +2 more outcomes

Companies that use 21st Century Oncology

Customer profile

Named customers5 records

Segments2 records

Ideal customer profiles1 record

21st Century Oncology technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

21st Century Oncology partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core.

  • Anadolu Medical CentercoreStrategic or Co-development PartnerAnadolu Medical Center is a leading multi-specialty cancer center in Turkey affiliated with Johns Hopkins Hospital. The partnership provides patients access to advanced treatments including CyberKnife M6, Varian Edge, and TrueBeam STx radiation systems. Anadolu has OECI accreditation and ESMO certification.
  • Bremen-Mitte HospitalcoreStrategic or Co-development PartnerBremen-Mitte is a multidisciplinary medical center treating 40,000 patients annually. The cancer center is certified by German Cancer Society (DKG) and European Cancer Society (ECC). Offers advanced treatments including NEOliquid liquid biopsy and HIPEC therapy.
  • Helios Clinic Berlin-BuchcoreStrategic or Co-development PartnerHelios Berlin-Buch is one of Germany's largest hospitals with over 200,000 patients annually, designated a cancer center by German Cancer Society (DKG). Offers IORT, HIPEC, PIPAC, and RFA treatments. Ranked by Focus magazine and Newsweek in 2021.
  • Asklepios Klinik BarmbekcoreStrategic or Co-development PartnerAsklepios Klinik Barmbek is part of Germany's largest hospital network, treating over 80,000 patients annually. Its oncology clinic is DKG-accredited. Features Da Vinci Robot, Gamma-knife, and VATS for advanced treatments. Ranked top 5 by MTQA.
  • Suraski Medical Center (Ichilov)coreStrategic or Co-development PartnerIchilov is a leading multi-specialty clinic in Israel, seeing over 400,000 patients and performing 34,000 operations annually. Ranked top 3 in Israel by Newsweek 2021. Features Novalis TrueBeam STx, Da Vinci robotic system, and CAR-T therapy.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

21st Century Oncology competitors and assessment

Company assessment

Direct peers

  • Medigo (Allianz Care): Medigo (now part of Allianz Care) is a medical tourism marketplace that helps international patients find and book treatment at accredited providers. It is directly comparable in intermediary model, content-driven discovery, and multi-country specialty hospital network.
  • BookingHealth: BookingHealth is a medical tourism platform that connects international patients with hospitals and clinics across multiple countries, including Germany and Israel. It mirrors 21st Century Oncology in business model (digital intermediary + lead generation) and target audience (cross-border patients seeking specialty treatment).
  • Treatment in Germany: Treatment in Germany is a medical tourism facilitator focused on routing international patients to German hospitals for oncology, cardiology, and other specialty care. It is highly comparable in country focus (Germany), partner type (DKG-accredited hospitals), and patient acquisition approach (content + SEO).
  • Qunomedical: Qunomedical is a digital health platform that connects patients with vetted clinics and hospitals worldwide, with a strong oncology and specialty focus. It is comparable as a content-and-concierge medical tourism intermediary for international patients.
  • Clinic Hunter: Clinic Hunter is a European medical tourism platform focused on connecting international patients with clinics and hospitals for specialty treatments. It is comparable in intermediary role, European hospital network, and content-led patient acquisition.
  • MyMeditravel: MyMeditravel is a medical tourism platform offering treatment packages across multiple countries and specialties. It is comparable as a content-driven, lead-generation intermediary linking international patients with overseas specialty hospitals.
  • Medical Departures: Medical Departures is a global medical tourism marketplace with verified provider listings, reviews, and booking support. It is directly comparable in business model (intermediary + verified providers) and cross-border specialty focus.
  • Healthbase: Healthbase is a US-based medical tourism facilitator connecting international patients with partner hospitals abroad. It shares the same US-domestic operating base, intermediary model, and multi-country specialty hospital network.
  • TourMedical: TourMedical is a medical tourism agency that arranges treatment and travel packages for patients seeking care abroad, with strong Turkey and Europe coverage. It is directly comparable as a cross-border oncology referral platform.

Others

  • Springer Nature: Springer Nature publishes peer-reviewed oncology content and clinical decision-support resources that international cancer patients and clinicians use. It is comparable to 21st Century Oncology only in the content and educational layer of its offering, not in patient referrals or commercial transactions.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key highlights5 records

Customer concentration

21st Century Oncology social profiles

Digital presence

21st Century Oncology compliance and trust

Trust signal

Compliance7 records

21st Century Oncology financial estimates

Financial estimate

Revenue estimate

Valuation estimate

21st Century Oncology leadership team

Management profile

Number of profiles

Profiles3 records

21st Century Oncology funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

21st Century Oncology M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 21st Century Oncology

What does 21st Century Oncology do?

21st Century Oncology operates an online medical tourism information portal that connects international cancer patients with accredited oncology treatment providers in Germany, Israel, Turkey, Spain, Czech Republic, and South Korea. The platform publishes educational content about cancer therapies (chemoembolization, HIFU, immunotherapy, targeted therapy, CAR-T, radiation, surgery) and profiles partner hospitals, then routes patient inquiries to those partner facilities for consultation and treatment.

Is 21st Century Oncology a public or private company?

21st Century Oncology is a private company. It is classified as venture growth investor backed and is currently operating.

When was 21st Century Oncology founded?

21st Century Oncology was founded in 1983. It employs 1,001 to 5,000 people.

Where is 21st Century Oncology based?

21st Century Oncology is headquartered in Fort Myers, United States, in the North America region.

How does 21st Century Oncology make money?

One revenue line is on record: hospital Referral/Lead Generation.

Who are 21st Century Oncology's main competitors?

Direct peers on record are Medigo (Allianz Care), BookingHealth, Treatment in Germany, Qunomedical, Clinic Hunter, MyMeditravel, Medical Departures, Healthbase and TourMedical. Springer Nature is listed as an others.

Does 21st Century Oncology have an API?

No public API is recorded for 21st Century Oncology.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireTerran Orbital's Gary Hobart Nominated for Orange County Business Journal's 15th Annual CFO of the Year AwardTerran Orbital Corporation announced that its Chief Financial Officer, Gary Hobart, has been nominated for the Orange County Business Journal's 15th Annual CFO of the Year Award. The nomination recognizes Hobart's leadership in corporate finance and his previous contributions to major deals, including the IPO of DigitalGlobe and the restructuring of 21st Century Oncology. The award ceremony is scheduled to take place on May 5, 2022.PR NewswireFormer 21st Century Oncology Chief Legal Officer and Executive Vice President Joins King & Spalding's Chicago OfficeKing & Spalding has announced the hire of Amy Garrigues as a partner in its Healthcare team in the Chicago office. Garrigues previously served as chief legal officer and executive vice president at 21st Century Oncology, an international cancer care provider, where she oversaw legal, risk management, physician compensation, licensing, and regulatory affairs. The hire is intended to expand the firm's healthcare regulatory presence in Chicago and grow its client base.Business Wire Blog21st Century Oncology Becomes Part of Australia’s GenesisCare to Increase Access to World Class Cancer Care in the U.S.GenesisCare acquired 21st Century Oncology, combining their networks to expand cancer care access in the U.S. The combined group of over 5,000 doctors will serve more than 400,000 patients annually. GenesisCare plans to install 10 linear accelerators in the first 100 days.PR Newswire21st Century Oncology collaborates with Landmark Cancer Center to expand patient access in Texas, Arkansas, Oklahoma and Missouri21st Century Oncology completed a joint venture partnership with Landmark Cancer Center to expand patient access to advanced cancer care across Texas, Arkansas, Oklahoma, and Missouri. The partnership adds 12 radiation oncologists, 7 medical oncologists, 2 radiologists, and a fellowship-trained breast surgeon, along with Landmark's 12 cancer centers and 5 medical oncology offices across four states. The transaction creates a combined network of over 200 radiation oncology treatment centers and 170 clinical offices, with a pending combination between GenesisCare and 21st Century Oncology also expected to close soon.PR Newswire21st Century Oncology Launches Social Campaign For Colorectal Cancer Awareness Month21st Century Oncology, the largest integrated cancer care network in the United States, has launched its third social awareness campaign in recognition of Colorectal Cancer Awareness Month, aiming to encourage early detection and preventive screenings. The campaign highlights that colorectal cancer is the second leading cancer killer for men and women, yet has an 89.9% five-year survival rate when detected early. The company operates through its Colorectal Institute in Fort Myers, Florida, and utilizes its network of 1,000 affiliated physicians to promote screening awareness across its treatment centers.PR Newswire21st Century Oncology creates Joint Venture with Landmark Cancer Center that increases patient access to advanced and integrated clinical cancer care21st Century Oncology announced a joint venture partnership with Landmark Cancer Centers, taking a majority stake in the combination that will expand 21st Century Oncology's network of cancer care facilities into the central United States. Landmark's 12 cancer centers and five medical oncology offices across Texas, Arkansas, Oklahoma, and Missouri will join 21st Century Oncology's existing 123 radiation oncology treatment centers and 170 clinical offices in 15 states. The transaction, expected to close pending regulatory approvals, also links to the previously announced GenesisCare and 21st Century Oncology combination, creating a global network of over 200 radiation oncology treatment centers.PR NewswireDr. Sonal Sura Joins 21st Century Oncology's Naples And Bonita Springs Office Locations21st Century Oncology announced that Dr. Sonal Sura has joined its Naples and Bonita Springs office locations as a radiation oncology specialist. Dr. Sura brings expertise in IMRT, IGRT, and Stereotactic Radiosurgery from her previous role at NYC Health + Hospitals/Elmhurst and training at Memorial Sloan Kettering Hospital. This addition is part of the company's strategy to maintain high standards of care across its network of treatment centers.PR Newswire21st Century Oncology Welcomes Oncologists Dr. Alex Hnatov And Dr. Jason Shumadine To Florida Locations21st Century Oncology announced the addition of radiation oncologists Dr. Alex Hnatov and Dr. Jason Shumadine to its Florida locations in Port Charlotte and Fort Myers. The expansion supports the network's goal of providing integrated cancer care with advanced technology to local communities. 21st Century Oncology operates 164 treatment centers across the United States and Latin America.PR NewswireCommunity-Based Centers On Par With Large Institutions: 21st Century Oncology Leads Research That Finds Better Way To Treat Early Cancer Of The VoiceboxResearchers from 21st Century Oncology published a study in The Journal of Radiation Oncology finding that patients with early-stage voice box cancer who received radiotherapy over 5.5 weeks (hypofractionation) had significantly improved cure rates compared to those treated over seven weeks, with 85% survival at 36 months versus 66%. The study analyzed 180 patients treated between 2000 and 2015 at 59 stand-alone centers affiliated with 21st Century Oncology, the nation's largest integrated cancer care network. The researchers hope these findings will spur consideration of more detailed standards for radiotherapy regimens, as hypofractionation is also less costly and more convenient for patients.PR Newswire21st Century Oncology and Physicians Regional Healthcare System To Lead Discussion on Men's Health21st Century Oncology and Physicians Regional Healthcare System announced they will co-host a free public men's health forum on February 1, 2020 in Naples, Florida, featuring six medical professionals presenting on topics including erectile dysfunction, prostate cancer, colorectal cancer, hernia, and enlarged prostate. The event will include a continental breakfast and a Q&A session with panelists. 21st Century Oncology is the nation's largest integrated cancer care network, operating 164 treatment centers across 15 U.S. states and seven Latin American countries.